☰

George Z. Cheng, Ph.D. - Publications

Affiliations: 
2007 Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Lang UE, Kocabayoglu P, Cheng GZ, Ghiassi-Nejad Z, Muñoz U, Vetter D, Eckstein DA, Hannivoort RA, Walsh MJ, Friedman SL. GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21. Oncogene. 32: 4557-64. PMID 23085750 DOI: 10.1038/Onc.2012.457  0.43
2008 Zhang W, Cheng GZ, Gong J, Hermanto U, Zong CS, Chan J, Cheng JQ, Wang LH. RACK1 and CIS mediate the degradation of BimEL in cancer cells. The Journal of Biological Chemistry. 283: 16416-26. PMID 18420585 DOI: 10.1074/Jbc.M802360200  0.614
2008 Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M, Xu LM, Costanzo C, Cheng JQ, Wang LH. Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. The Journal of Biological Chemistry. 283: 14665-73. PMID 18353781 DOI: 10.1074/Jbc.M707429200  0.642
2008 Cheng GZ, Park S, Shu S, He L, Kong W, Zhang W, Yuan Z, Wang LH, Cheng JQ. Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Current Cancer Drug Targets. 8: 2-6. PMID 18288938 DOI: 10.2174/156800908783497159  0.629
2008 Cheng GZ, Zhang W, Wang LH. Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Research. 68: 957-60. PMID 18281467 DOI: 10.1158/0008-5472.Can-07-5067  0.655
2007 Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Research. 67: 1979-87. PMID 17332325 DOI: 10.1158/0008-5472.Can-06-1479  0.658
2007 Yang L, Sun M, Sun XM, Cheng GZ, Nicosia SV, Cheng JQ. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212. The Journal of Biological Chemistry. 282: 10981-7. PMID 17311912 DOI: 10.1074/Jbc.M700445200  0.404
2005 Kim D, Cheng GZ, Lindsley CW, Yang H, Cheng JQ. Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. Current Opinion in Investigational Drugs (London, England : 2000). 6: 1250-8. PMID 16370391  0.437
2005 Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene. 24: 7482-92. PMID 16288295 DOI: 10.1038/Sj.Onc.1209088  0.524
2004 Benzeno S, Narla G, Allina J, Cheng GZ, Reeves HL, Banck MS, Odin JA, Diehl JA, Germain D, Friedman SL. Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Research. 64: 3885-91. PMID 15172998 DOI: 10.1158/0008-5472.Can-03-2818  0.416
Show low-probability matches.